New York, New York Clinical Trials

A listing of New York, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 510 clinical trials
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

ixazomib
thalidomide
carfilzomib
stem cell transplantation
bortezomib
Investigational Site Number 8400001
 (3.4 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations
QA_Study Trial 01

Test Comment here

QA_Site01
 (7.8 away) Contact site
  • 0 views
  • 23 Jan, 2023
  • 1 location
Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata (APACCO) updated  

Apremilast mediates its clinical effect through the cAMP-PKA-NFkappaB pathway which results in a clinical picture changes to a decrease of all signs of inflammation.Due to the NFkappaB mediated chronical inflammation in the pathogenesis of acne conglobata, a treatment with Apremilast seems to be an effective option.In this study, treatment with …

testprivacy2US
 (9.4 away)
  • 0 views
  • 14 Mar, 2022
  • +3 other locations
RJ_Study4  

Acne

Privacy countryUs
 (9.4 away)
  • 0 views
  • 14 Mar, 2022
  • +4 other locations
sandeep Testing 11821 1  

test

Diabetes
 (7.8 away)
  • 0 views
  • 17 Apr, 2023
  • +2 other locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

James J. Peters VA Medical Center
 (3.0 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI test  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Accepts healthy volunteers
James J. Peters VA Medical Center
 (3.0 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations
Distal Peripheral Neuropathy in Type 2 Diabetes (DSP/DM)  

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency …

New York University, Division of Special Studies in Symptom Management
 (7.3 away)
  • 0 views
  • 26 Sep, 2022
  • +2 other locations
Single Session of Anodal Cerebellar vs Cerebral Transcranial Direct Current Stimulation in Stroke Patients

To compare the effect of anodal cerebellar transcranial direct current stimulation (ctDCS) vs anodal cerebral direct current stimulation on balance, mobility and cognition in stroke patients in stroke patients

heart institute
 (9.4 away) Contact site
  • 0 views
  • 23 Nov, 2021
  • 1 location
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

The primary objective of this study is to evaluate the safety and clinical activity of NKG2D-based CAR-T cells infusion in the treatment of relapsed/refractory NKG2DL+ solid tumors.

site a
 (9.4 away) Contact site
  • 0 views
  • 23 Nov, 2021
  • 1 location